Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Becilli
Institutions:
Bambino Gesù Children's Hospital,
Istituti di Ricovero e Cura a Carattere Scientifico,
Fondazione Bambino Gesù
Observed institutions:
Università Campus Bio-Medico,
Bambino Gesù Children's Hospital,
Istituti di Ricovero e Cura a Carattere Scientifico,
Fondazione Bambino Gesù
ORCID:
0000-0002-8874-4092
Observed ORCID:
0000-0002-8874-4092
OpenAlex ID:
A5019739895
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial
2025
·
Franco Locatelli
, Daria Pagliara
, et al.
·
Nature Medicine
·
89
Fratricide-resistant CD7-CAR T cells in T-ALL
2024
·
Bernice L. Z. Oh
, Noriko Shimasaki
, et al.
·
Nature Medicine
·
89
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
2024
·
Rebecca Nicolai
, Pietro Merli
, et al.
·
Arthritis & Rheumatology
·
76
Allogeneic, donor-derived, second-generation, CD19-CAR-T cell for the treatment of pediatric relapsed/refractory BCP-ALL
2023
·
Francesca del Bufalo
, Marco Becilli
, et al.
·
Blood
·
74
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
·
Clinical Cancer Research
·
60
PDF
TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis
2023
·
Pietro Merli
, Mattia Algeri
, et al.
·
Blood
·
53
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
2025
·
Concetta Quintarelli
, Francesca Del Bufalo
, et al.
·
Nature Medicine
·
48
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
2023
·
Riccardo Masetti
, Francesco Baccelli
, et al.
·
Blood Advances
·
44
PDF
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia
2020
·
Pietro Merli
, Mattia Algeri
, et al.
·
Frontiers in Immunology
·
35
PDF
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells
2024
·
Michele Pezzella
, Concetta Quintarelli
, et al.
·
Journal of Hematology & Oncology
·
31
PDF
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
2026
·
Marco Becilli
, Markus Metzler
, et al.
·
Nature Medicine
·
26
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation
2024
·
Mattia Algeri
, Michele Massa
, et al.
·
Haematologica
·
22
PDF
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)
2019
·
Ombretta Annibali
, Stefan Hohaus
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
22
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors
2022
·
Pietro Merli
, Pietro Crivello
, et al.
·
British Journal of Haematology
·
20
PDF
Utilization of volumetric absorptive microsampling and dried plasma spot for quantification of anti-fungal triazole agents in pediatric patients by using liquid chromatography-tandem mass spectrometry
2023
·
Raffaele Simeoli
, Sara Cairoli
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
16
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
2025
·
Swati Naik
, Richard Aplenc
, et al.
·
Blood Advances
·
11
PDF
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse
2025
·
Francesca Del Bufalo
, Marco Becilli
, et al.
·
Blood Advances
·
10
PDF
Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes
2024
·
Federica Galaverna
, Sara Flamini
, et al.
·
Haematologica
·
8
αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes
2022
·
Pietro Merli
, Daria Pagliara
, et al.
·
Haematologica
·
8
PDF
Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?
2021
·
Stefania Gaspari
, Valentina Di Ruscio
, et al.
·
Frontiers in Oncology
·
8
PDF
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
2026
·
Marco Becilli
, Pietro Merli
, et al.
·
Blood
·
7
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease
2023
·
Mattia Algeri
, Marco Becilli
, et al.
·
Expert Review of Clinical Immunology
·
7
Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosis
2025
·
Isabella Guzzo
, Marco Becilli
, et al.
·
Pediatric Nephrology
·
5
Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013
2026
·
Franco Locatelli
, Barbara Buldini
, et al.
·
Journal of Hematology & Oncology
·
4
Sensitivity of Pediatric Myelodysplastic Syndromes With Excess of Blasts With UBTF – TD to Venetoclax/Azacitidine
2025
·
Pietro Merli
, Riccardo Masetti
, et al.
·
American Journal of Hematology
·
4
PDF
Show more works
View as search
Works count:
63
Citation count:
793
H-index:
15
I10-index:
17
Year
Topic
Type